One of the lead saRNAs, RAG7-133, can significantly upregulate the expression of LHPP mRNA and protein and thereby inhibit HCC proliferation and migration and has synergy with a number of small molecular anticancer drugs in inhibiting HCC proliferation. The gene discussed is LHPP; the disease is hepatocellular carcinoma.